Order Article Reprints

Zheng J-Q, Lin C-H, Lee H-H, Wang W-K, Tong Y-S, Lee K-Y, Chiu H-W, Lin Y-F. Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation. Biomedicines. 2021; 9(12):1896. https://doi.org/10.3390/biomedicines9121896

Zheng, Jing-Quan, Che-Hsuan Lin, Hsun-Hua Lee, Wen-Ke Wang, Yiu-Shun Tong, Kang-Yun Lee, Hui-Wen Chiu, and Yuan-Feng Lin. 2021. "Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation" Biomedicines 9, no. 12: 1896. https://doi.org/10.3390/biomedicines9121896

Zheng, J.-Q., Lin, C.-H., Lee, H.-H., Wang, W.-K., Tong, Y.-S., Lee, K.-Y., Chiu, H.-W., & Lin, Y.-F. (2021). Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation. Biomedicines, 9(12), 1896. https://doi.org/10.3390/biomedicines9121896